Diabetes pill shows promise in Real-World mexican patients
NCT ID NCT05316662
Summary
This study observed how the diabetes medication Rybelsus® (oral semaglutide) worked for adults with type 2 diabetes in everyday Mexican clinics. Over 8-10 months, researchers tracked changes in participants' blood sugar levels and body weight. The goal was to see how well the once-daily pill performed outside of strict clinical trials.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CICEJ Centro de Investigacion Clinica Endocrinologica de Jalisco SC
Guadalajara, Jalisco, 44670, Mexico
-
Centro de Investigacion Clinica Endocrinologica de Jalisco
Guadalajara, Jalisco, 44670, Mexico
Conditions
Explore the condition pages connected to this study.